Impact of Isolation Methods on Extracellular Vesicle Functionality In Vitro and In Vivo

© 2023 Wiley-VCH GmbH..

This study compares the impact of two isolation methods, ultracentrifugation (UC) and size exclusion chromatography (SEC), on small extracellular vesicles (sEVs) from primary human cardiac mesenchymal-derived progenitor cells (CPCs). sEV_UC and sEV_SEC exhibit similar size, marker expression, and miRNA cargo, but sEV_UC contains notably higher total protein levels. In vitro assays show that sEV_UC, despite an equal particle count, induces more robust ERK phosphorylation, cytoprotection, and proliferation in iPS-derived cardiomyocytes (iPS-CMs) compared to sEV_SEC. sEV_UC also contains elevated periostin (POSTN) protein levels, resulting in enhanced focal adhesion kinase (FAK) phosphorylation in iPS-CMs. Importantly, this effect persists with treatment with soluble free-sEV protein fraction from SEC (Prote_SEC), indicating that free proteins like POSTN in sEV_UC enhance FAK phosphorylation. In vivo, sEV contamination with soluble proteins doesn't affect cardiac targeting or FAK phosphorylation, underscoring the intrinsic tissue targeting properties of sEV. These findings emphasize the need for standardized sEV isolation methods, as the choice of method can impact experimental outcomes, particularly in vitro.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Advanced biology - 8(2024), 2 vom: 01. Feb., Seite e2300185

Sprache:

Englisch

Beteiligte Personen:

Balbi, Carolina [VerfasserIn]
Parisse, Pietro [VerfasserIn]
Vondracek, Hendrik [VerfasserIn]
Lazzarini, Edoardo [VerfasserIn]
Bolis, Sara [VerfasserIn]
Fertig, Tudor E [VerfasserIn]
Gherghiceanu, Mihaela [VerfasserIn]
Barile, Lucio [VerfasserIn]
Vassalli, Giuseppe [VerfasserIn]

Links:

Volltext

Themen:

EC 2.7.10.2
EV functionality
Extracellular vesicles
Focal Adhesion Protein-Tyrosine Kinases
Isolation methods
Journal Article
Size exclusion chromatography
Ultracentrifugation

Anmerkungen:

Date Completed 14.02.2024

Date Revised 14.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/adbi.202300185

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363765417